Korean

R&D Highlights

R&D Pipeline
Pipeline
HOME >  R&D >  Pipeline
  • 01

    By 2023, Completing global clinical trial phase 2A
    1 ongoing phase 2,
    1 Pre-clinical study
    1 Discovery of Candidate

  • 02

    Vision of 2025 MC/MT
    Global R&D Venture
    with MCMT technology

  • MT101
    (HX023)

    MT102

    MT103

    MT104

  • Parkinson's disease

    Inflammatory bowel disease
    (microbiome-related)

    Type 2 diabetes
    (ITIH1,New mechanism)

    Dementia
    (microbiome-related)

  • Preclinical

    Candidate selection

    Candidate selection

    Candidate selection
    /Preclinical/
    POC clinical

  • IND/Clinical 1,2a

    Preclinical

    Preclinical

    Preclinical/IND

  • Clinical 2a

    Simple clinical/IND

    Preclinical
    /Simple clinical

    Phase 2 Clinical

  • Clinical 2a complete
    Pre-IPO

    Phase 2 start

    IND

    Phase 2 in progress

  • LO/2b public development
    IPO

    Phase 2 in progress

    Phase 1/2 start

    Phase 2 start/
    interim analysis